Merantix Capital

Merantix Capital Merantix Capital, founded in 2016, is part of the Merantix group. Europe's leading AI ecosystem combining a venture studio and capital arm. A €100M fund is being raised in 2025 (the largest yet), following a €35M fund (2020). Check sizes run €500K-€4M at pre-seed to seed stage for AI-native companies. The portfolio of 29 investments includes Vara (AI breast cancer detection), Cambrium (AI-powered designer proteins), and Ficus (medical records). The venture studio model is disti